Post Market Clinical follow up Study of TTK Chitra Heart Valves

Post Market Clinical follow up Study of TTK Chitra Heart Valves Model TC1 (PMCFU.2-TCHV-TC1) Prospective, Single-centre, Single arm, Clinical follow-up Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2015/08/006094

Enrollment

250

Registered

2015-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z952- Presence of prosthetic heart valve

Interventions

Intervention1: NIL (Not Applicable).: NIL (Not Applicable). Control Intervention1: NIL (Not Applicable).: NIL (Not Applicable).

Eligibility

Inclusion criteria

Inclusion criteria: a) Individuals at least 18 years old and able to give informed consent. b) Patient implanted with study device as per instructions for use during the said period. c) The patient (or legal guardian) has signed an informed consent, and agreeing to the data collection.

Exclusion criteria

Exclusion criteria: a) Patient implanted with any other valve apart from the study device. b) Any patient actively participating in any other study of an investigational drug or device to be excluded.

Design outcomes

Primary

Measure	Time frame
For details, please refer to the brief summary.Timepoint: For details, please refer to the brief summary.	—

Secondary

Measure	Time frame
Not Applicable.Timepoint: Not Applicable.	—

Countries

India

Contacts

Public ContactDr Shariq Anwar

TTK Healthcare Ltd.

rkn@ttkhealthcare.com04712707002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026